Shanghai Henlius Biotech names CFO
Yingbo Mao has previously worked at Coca-Cola and has over two decades of experience in financial management.
Shanghai Fosun Pharmaceutical Group's Shanghai Henlius Biotech has announced the appointment of Yingbo Mao as the firm's new chief financial officer (CFO), effective from Monday, July 1, 2024.
Sign-in to access CorporateTreasurer content.
Please sign in to your subscription to unlock full access to our premium CT resources.
Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial. Click the link to get started.
Note: This free trial is a one-time offer. You are eligible for one free trial per year.
If you are a treasurer, CFO or senior finance professional at a corporate, please register to the website here.
Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at subscriptions@thecorporatetreasurer.com. Our subscription team will be happy to assist you.
© Haymarket Media Limited. All rights reserved.
Top news, insights and analysis every Tuesday & Thursday
Free registration gives you access to our email newsletters
for unlimited access to all articles, newsletters
